Amy McBride Wendell, Director at Axogen, Inc. (AXGN), sold 5,000 shares at $20.02 ($100K) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Open-market sale of $100k AXGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SOLV | BUY | 2026-03-11 | $100K | — | Filing → |
| AXGN | SELL | 2025-12-17 | $2.4M | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |